|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
$179,961
|
N/A
|
(NCI)
|
|
Novel targeted therapeutics for multiple myeloma
|
5R21CA153155-02
|
$162,581
|
$162,581
|
AGYIN, JOSEPH
|
UNIV OF TX HSC, SA
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-09
|
$216,434
|
$41,122
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$1,451,134
|
$145,113
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture
|
ZIA CP010119-10527
|
$441,719
|
$220,860
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Host-tumor cell interaction in myeloma: therapeutic applications
|
5P01CA078378-13
|
$1,974,463
|
$1,974,463
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
SPORE in Myeloma
|
5P50CA100707-10
|
$2,300,000
|
$2,300,000
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-20
|
$278,781
|
$278,781
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INSTITUTE
|
|
Protein regulation in multiple myeloma
|
ZIABC011312
|
$82,661
|
$82,661
|
Annunziata, Christina
|
CCR (NCI)
|
|
SOUTHEAST CANCER CONTROL COSORTIUM, INC
|
3U10CA045808-18S1
|
$323,511
|
$6,470
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-26
|
$1,476,477
|
$29,530
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-38
|
$354,850
|
$67,422
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
5U10CA052667-22
|
$536,603
|
$32,196
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
SWOG Community Clinical Oncology Program Research Base
|
2U10CA037429-28
|
$1,371,233
|
$109,699
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-33S1
|
$196,749
|
$31,480
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group Biorepository
|
3U24CA114748-07S1
|
$697,714
|
$69,771
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group Treatment Grant
|
5U10CA032102-33
|
$8,923,498
|
$1,427,760
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group Biorepository
|
5U24CA114748-07
|
$1,125,491
|
$112,549
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Multiple Myeloma - Yale case-control
|
ZIA CP010123-02380
|
$50,923
|
$50,923
|
Baris, Dalsu
|
DCEG (NCI)
|
|
Multiple Myeloma BOAC study
|
ZIA CP010136-10523
|
$11,875
|
$11,875
|
Baris, Dalsu
|
DCEG (NCI)
|
|
Growth Control in Multiple Myeloma
|
5P01CA055819-18
|
$3,627,570
|
$3,627,570
|
BARLOGIE, BART
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-28
|
$820,953
|
$24,629
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA042014-23S1
|
$75,000
|
$750
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
5P30CA042014-23
|
$1,454,512
|
$14,545
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
The Gulf Coast MBCCOP
|
3U10CA128536-05S1
|
$391,891
|
$19,595
|
BEEKER, THADDEUS
|
PROVIDENCE HOSPITAL (MOBILE, AL)
|
|
Iowa Oncology Research Association
|
2U10CA035101-27
|
$669,579
|
$20,087
|
BEHRENS, ROBERT
|
IOWA ONCOLOGY RESEARCH ASSOCIATION
|
|
Targeted Radiotherapy with 90Y-BC8 Monclonal Antibody, Fludarabine and TBI Follow
|
5R21CA155911-02
|
$340,471
|
$340,471
|
BENSINGER, WILLIAM
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
ECOG Clinical Trials
|
5U10CA017145-37
|
$415,756
|
$78,994
|
BENSON, AL
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Cancer Center Support Grant
|
2P30CA006516-47
|
$11,164,583
|
$446,583
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S1
|
$56,572
|
$2,263
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S2
|
$75,000
|
$3,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA006516-47S3
|
$50,000
|
$2,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Hawaii Minority-Based Clinical Community Oncology Program
|
5U10CA063844-19
|
$543,533
|
$10,871
|
Berenberg, Jeffrey
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Molecular Pathogenesis of Multiple Myeloma
|
5R01CA133966-04
|
$322,040
|
$322,040
|
BERGSAGEL, PETER
|
MAYO CLINIC ARIZONA
|
|
Comparative Pharmaco-oncogenomics of Myeloma Drug Resistance
|
5R01CA136671-04
|
$322,040
|
$322,040
|
BERGSAGEL, PETER
|
MAYO CLINIC ARIZONA
|
|
Eastern Cooperative Oncology Group
|
5U10CA049957-24
|
$355,104
|
$67,470
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MED CTR
|
|
Chaetocin as a Potential Therapy for Multiple Myeloma
|
5R01CA125750-05
|
$346,123
|
$346,123
|
BIBLE, KEITH
|
MAYO CLINIC
|
|
To establish the BC Cancer Agency - Vancouver Centre as a major SWOG centre
|
5U10CA142559-03
|
$131,854
|
$21,097
|
BLANKE, CHARLES
|
BRITISH COLUMBIA CANCER AGENCY
|
|
Erythropoietin Blockade for the Treatment of Cancer
|
5R01CA135357-05
|
$402,553
|
$100,638
|
Blau, C. Anthony
|
UNIVERSITY OF WASHINGTON
|
|
Molecular Mechanism of Action of Phorbol Ester
|
ZIABC005270
|
$1,371,351
|
$68,568
|
Blumberg, Peter
|
CCR (NCI)
|
|
Proteosome inhibitor sensitivity in multiple myeloma: The role of ER stress
|
5R01CA127910-06
|
$311,976
|
$311,976
|
BOISE, LAWRENCE
|
EMORY UNIVERSITY
|
|
Arsenic-induced apoptosis in myeloma
|
5R01CA129968-04
|
$362,855
|
$362,855
|
BOISE, LAWRENCE
|
EMORY UNIVERSITY
|
|
Selective Inhibition of HDAC6 in Cancer Therapy
|
5K08CA128972-05
|
$139,320
|
$139,320
|
BRADNER, JAMES
|
DANA-FARBER CANCER INSTITUTE
|
|
A genome-wide methylation study of epigenetic contributions to multiple myeloma
|
5R21CA155951-02
|
$219,568
|
$219,568
|
Brown, Elizabeth
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Immune Evasion by Multiple Myeloma: Role of the Rho Kinase Signaling Pathway
|
1R01CA161178-01A1
|
$323,181
|
$323,181
|
Brutkiewicz, Randy
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-14
|
$95,411
|
$18,128
|
BUBLEY, GLENN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Innate Immunity: Elucidation and Modulation for Cancer Therapy
|
2P01CA095426-11
|
$2,058,483
|
$226,433
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-36S1
|
$49,250
|
$493
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-36S2
|
$140,000
|
$1,400
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA016058-36S3
|
$75,000
|
$750
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
Total relevant funding to Multiple Myeloma for this search: $61,283,378
|